(91 days)
No
The summary does not mention AI, ML, or any related concepts, and the device description focuses on standard infrared therapy components and functions.
Yes.
The device's intended use is to provide topical heating for the purpose of elevating tissue temperature for temporary relief of minor muscle and joint pain, muscle spasm, pain and stiffness associated with arthritis, promoting relaxation of muscle tissue, and temporarily increasing local blood circulation, which are all therapeutic benefits.
No
The device is described as an infrared therapy device used for pain relief and increased blood circulation, which are therapeutic functions, not diagnostic ones. There is no mention of it being used to identify or diagnose medical conditions.
No
The device description explicitly mentions hardware components such as a therapy table, touch screen, emitter, handpiece, and battery pack, in addition to software.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use clearly describes a therapeutic purpose – providing topical heating for pain relief, muscle relaxation, and increased blood circulation. This is a physical therapy or pain management application, not a diagnostic one.
- Device Description: The device emits infrared energy and is used externally on the body. IVD devices are used to examine specimens (like blood, urine, or tissue) in vitro (outside the body) to diagnose diseases or conditions.
- Lack of Diagnostic Elements: There is no mention of analyzing biological samples, detecting biomarkers, or providing diagnostic information.
Therefore, this device falls under the category of a therapeutic device, not an IVD.
N/A
Intended Use / Indications for Use
The device is indicated for emitting energy in the Infrared Spectrum to provide topical heating for the purpose of elevating tissue temperature for temporary relief of minor muscle and joint pain, muscle spasm, pain and stiffness associated with arthritis and promoting relaxation of the muscle tissue and to temporarily increase local blood circulation.
Product codes
ILY
Device Description
K-1200 is an infrared therapy portable device, easy to transport, usable also without electrical net, thanks to a battery pack. It is composed of a touch screen for managing all the device functions, an emitter, an handpiece for the delivery of light, software and an on/off button to activate and deactivate the infrared emission.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Not Found
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc)
Not Found
§ 890.5500 Infrared lamp.
(a)
Identification. An infrared lamp is a device intended for medical purposes that emits energy at infrared frequencies (approximately 700 nanometers to 50,000 nanometers) to provide topical heating.(b)
Classification. Class II (special controls). The device, when it is an infrared therapeutic heating lamp, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 890.9.
0
Kog 149]
D of
3
510(K) Premarket SUBMISSION
510(K) K-1200 HEAT LAMP SECTION_5: STATEMENT OF SUMMARY
Rev. 0 Sec. 5 Page 1 of
SUMMARY OF SAFETY AND EFFECTIVENESS
· SUBMITTED BY:
AUG 1 9 2009
ELTECH s.r.i.
Via Castagnole, 20/H 31100 Treviso, Italy Phone: 0039 422 210 430
Fax: 0039 422 297 137
CONTACT:
Official Correspondent:
dr. Richard Albright K-Laser USA 311 So. Royal Oaks Blvd Suite 140-A Franklin, TN 37064 Phone: 866-595-7749
US Agent:
dr. Richard Albright ,PRES K-Laser USA 311 So. Royal Oaks Blvd 140-A Franklin, TN 37064 Phone: 866-595-7749 Fax: 615-261-3535 Email: ralbright@k-laserusa.com
1. DEVICE NAME (Trade/common, and classification):
Proprietary name: K-LASER Common/usual name: K-1200 Classification name: Therapy Probe. Classification: Class II Regulation Nos.: 890.5500 Product Codes: ILY
1
209/491 Page (2)
510(K) PREMARKET SUBMISSION
510(K) K-1200 HEAT L SECTION 5: STATEMENT OF SUMMARY
Rev. . O Sec. 5 Page
2. PREDICATE DEVICES:
K-LASER - Cleared under K050070 LCT-1000 – Cleared under K070400
3. PERFORMANCE STANDARDS:
K-1200 conforms to the applicable requirements of 21 CFR section 1010 (Performance Standards for Electronic Products: General) and 21 CFR sections 1040.10 and 1040.11 (Performance Standards for Light-Emitting Products).
4. DESCRIPTION:
K-1200 is an infrared therapy table device, easy to transport, usable also without electrical net, thanks to a battery pack. It is composed of a touch screen for managing all the device functions, an emitter, an handpiece for the delivery of light, software and an on/off button to activate and deactivate the infrared emission.
ട്. INTENDED USE/ INDICATIONS FOR USE:
The device is indicated for emitting energy in the Infrared Spectrum to provide topical heating for the purpose of elevating tissue temperature for temporary relief of minor muscle and joint pain, muscle spasm, pain and stiffness associated with arthritis and promoting relaxation of the muscle tissue and to temporarily increase local blood circulation.
The intended Use/Indications For Use stated herein are identical to the cleared indications for the predicate device.
SUBSTANTIAL EQUIVALENCE (SE) RATIONALE: 6.
K-1200 generates infrared therapy for treatment of selected medicals conditions and shares the same basic characteristics and the same intended use as the predicate device. Therefore, the proposed device is substantially equivalent to the K-LASER, cleared under K050070 and LCT-1000, cleared under K070400.
2
K09149
Page 3 of 6
510(K) Premarket SUBMISSION
510(K) K-1200 HEAT LAMP SECTION 5: STATEMENT OF SUMMARY
Rev. 0 Sec. 5 Page 3
7. SAFETY AND EFFECTIVENESS:
There are no substantive differences between the product defined in this 510(k) submission and the predicate device. They are similar to the technologies that are currently used in other similar medical devices. They were developed and documented under Eltech's mature Quality Managerment System, under The Quality System Regulation, 21 CFR Part 820, under design/change control, and verified/validated to applicable standards/guidance documents. Besides, Eltech's Quality Assurance System is certified by CERMET, notified body n. CE 0476, according to Annex II of 93/42 EEC Directive, transposed in Italy by DIgs. n. 46 of 24 February 1997.
K-1200 is safe and effective when used as indicated in specific applications under a clinician's supervision/therapy program.
Signed:__ and the signature of Elizabeth Jackson
Eltech s.r.l. Francesco Zanata President
Date: 14 May, 2009
3
Image /page/3/Picture/1 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo consists of a stylized depiction of an eagle or bird-like figure with three wing-like shapes. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular fashion around the bird-like figure. The logo is black and white.
Food and Drug Administration 10903 New Hampshire Avenue Document Mail Center - WO66-G609 Silver Spring, MD 20993-0002
Eltech s.r.l % K-Laser USA Dr. Richard Albright 311 So. Royal Oaks Boulevard Suite 140-A Franklin, Tennessee 37064
Re: K091497
AUG 1 9 2009
Trade/Device Name: K-1200 Regulation Number: 21 CFR 890.5500 Regulation Name: Infrared lamp Regulatory Class: Class II Product Code: ILY Dated: July 2, 2009 Received: July 21, 2009
Dear Dr. Albright:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set
4
Page 2 - Dr. Richard Albright
forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/cdrh/mdr/ for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours,
ely yours,
F/L
Mark N. Melkerson Director Division of Surgical, Orthopedic and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
5
KU91497
510(K) Premarket SUBMISSION
510(K) K-1200 HEAT LAMP SECTION_4: STATEMENT OF INDICATION FOR USE
INDICATIONS FOR USE
Device Name: K-1200
Indications for Use:
The device is indicated for emitting energy in the Infrared Spectrum to provide topical heating for the purpose of elevating tissue temperature for temporary relief of minor muscle and joint pain, muscle spasm, pain and stiffness associated with arthritis and promoting relaxation of the muscle tissue and to temporarily increase local blood circulation.
Prescription Use × (Part 21 CFR 801 Subpart D)
AND/OR
Over-The-Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Niel Reber for mxm
Division of Surgical, Orthopedic, and Restorative Devices
510(k) Number K091497
510(K) Submission